株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

陽子線治療の米国市場:患者数、償還政策、陽子線治療センターで治療中の患者数

United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers

発行 Renub Research 商品コード 484586
出版日 ページ情報 英文 147 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
陽子線治療の米国市場:患者数、償還政策、陽子線治療センターで治療中の患者数 United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers
出版日: 2019年08月01日 ページ情報: 英文 147 Pages
概要

当レポートでは、米国の陽子線治療市場について調査分析し、顕在市場と潜在市場を対象に、患者数、がんの種類、治療センターのリスト、経済性、企業分析などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場 (顕在・潜在) - 米国の陽子線治療市場

  • 陽子線治療:顕在市場
  • 陽子線治療:潜在市場

第5章 患者数 - 米国の陽子線治療

  • 実数
  • 潜在数

第6章 がんの種類 - 米国の陽子線治療の患者数

  • 中枢神経系 (CNS) 腫瘍
  • 眼球内黒色腫
  • 下垂体腫瘍
  • 頭蓋底/中軸骨格腫瘍
  • 頭頸部がん
  • 肺がん
  • 後腹膜肉腫
  • 小児がん (18歳以下)
  • 消化管がん
  • 尿路がん
  • 女性向け・骨盤内臓器がん
  • 前立腺がん
  • 乳がん
  • その他

第7章 がんの種類 - 米国の陽子線治療市場

  • 中枢神経系 (CNS) 腫瘍
  • 眼球内黒色腫
  • 下垂体腫瘍
  • 頭蓋底/中軸骨格腫瘍
  • 頭頸部がん
  • 肺がん
  • 後腹膜肉腫
  • 小児がん (18歳以下)
  • 消化管がん
  • 尿路がん
  • 女性向け・骨盤内臓器がん
  • 前立腺がん
  • 乳がん
  • その他

第8章 米国 - 陽子線治療センターのリスト

  • 稼働中
  • 建設中
  • 計画中

第9章 センター別 - 治療中の患者数

  • Loma Linda (LLUMC) Proton Therapy Center
  • UCSF - CNL Proton Therapy Center
  • Boston (NPTC) Proton Therapy Center
  • Bloomington (MPRI, 2) Proton Therapy Center
  • Houston (MD Anderson) Proton Therapy Center
  • UFPTI Jacksonville Proton Therapy Center
  • Oklahoma City (ProCure PTC) Proton Therapy Center
  • CDH Warrenville Proton Therapy Center
  • Philadelphia (Upenn) Proton Therapy Center
  • Hampton (HUPTI) Proton Therapy Center
  • New Jersey (ProCure PTC) Proton Therapy Center
  • Seattle (SCCA ProCure PTC) Proton Therapy Center
  • St. Louis (S. Lee King PTC) Proton Therapy Center
  • Provision Center for Proton Therapy, Knoxville, TN
  • San Diego (Scripps PTC) (2014 - 2017)
  • Shreveport (Willis Knighton) Proton Therapy Center
  • Jacksonville (Ackerman CC) Proton Therapy Center
  • Rochester (Mayo PBTC) Proton Therapy Center
  • Brunswick (Laurie PC) Proton Therapy Center
  • Irving (Texas Center for PT) Proton Therapy Center
  • Memphis (St. Jude PTC) Proton Therapy Center
  • Phoenix (Mayo PBTC) Proton Therapy Center
  • Baltimore (Maryland PTC) Proton Therapy Center
  • Cincinnati (Children's PTC) Proton Therapy Center
  • Orlando (Orlando Health PTC) Proton Therapy Center
  • Cleveland (UH Sideman PTC) Proton Therapy Center

第10章 陽子線治療 - 償還政策

  • 患者向け
  • 医療機関・ステークホルダー・メーカー向け

第11章 標準的な陽子線治療センターの構成要素

  • 陽子加速器
  • ビーム輸送システム
  • ビーム提供システム
  • ノズル
  • 治療計画システム
  • 画像ビューア
  • 患者ポジショニングシステム (PPS)
  • 人的資源

第12章 企業分析

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

第13章 促進要因

第14章 課題

図表

List of Figures:

  • Figure 2-1: United States - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: United States - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: United States - Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 - 2018
  • Figure 4-2: United States - Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2019 - 2025
  • Figure 4-3: United States - Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 - 2018
  • Figure 4-4: United States - Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2019 - 2025
  • Figure 4-5: United States - Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 - 2018
  • Figure 4-6: United States - Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2019 - 2025
  • Figure 4-7: United States - Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 - 2018
  • Figure 4-8: United States - Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2019 - 2025
  • Figure 4-9: United States - Proton Therapy Patient by Head and Neck Cancer (Number), 2009 - 2018
  • Figure 4-10: United States - Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2019 - 2025
  • Figure 4-11: United States - Proton Therapy Patient by Lung Cancer (Number), 2009 - 2018
  • Figure 4-12: United States - Forecast for Proton Therapy Patient by Lung Cancer (Number), 2019 - 2025
  • Figure 4-13: United States - Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 - 2018
  • Figure 4-14: United States - Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2019 - 2025
  • Figure 4-15: United States - Proton Therapy Patient by Pediatric Cancer (Number), 2009 - 2018
  • Figure 4-16: United States - Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2019 - 2025
  • Figure 4-17: United States - Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 - 2018
  • Figure 4-18: United States - Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2019 - 2025
  • Figure 4-19: United States - Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 - 2018
  • Figure 4-20: United States - Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2019 - 2025
  • Figure 4-21: United States - Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 - 2018
  • Figure 4-22: United States - Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2019 - 2025
  • Figure 4-23: United States - Proton Therapy Patient by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-24: United States - Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-25: United States - Proton Therapy Patient by Breast Cancer (Number), 2009 - 2017
  • Figure 4-26: United States - Forecast for Proton Therapy Patient by Breast Cancer (Number), 2019 - 2025
  • Figure 4-27: United States - Proton Therapy Patient by Other Cancer (Number), 2009 - 2018
  • Figure 4-28: United States - Forecast for Proton Therapy Patient by Other Cancer (Number), 2019 - 2025
  • Figure 5-1: United States - Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 - 2018
  • Figure 5-2: United States - Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2019 - 2025
  • Figure 5-3: United States - Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 - 2018
  • Figure 5-4: United States - Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2019 - 2025
  • Figure 5-5: United States - Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 - 2018
  • Figure 5-6: United States - Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2019 - 2025
  • Figure 5-7: United States - Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 - 2018
  • Figure 5-8: United States - Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2019 - 2025
  • Figure 5-9: United States - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-10: United States - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-11: United States - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-12: United States - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-13: United States - Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 - 2018
  • Figure 5-14: United States - Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2019 - 2025
  • Figure 5-15: United States - Proton Therapy Market by Pediatric Cancer (Million US$), 2009 - 2018
  • Figure 5-16: United States - Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2019 - 2025
  • Figure 5-17: United States - Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-18: United States - Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-19: United States - Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-20: United States - Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-21: United States - Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 - 2018
  • Figure 5-22: United States - Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2019 - 2025
  • Figure 5-23: United States - Proton Therapy Market by Prostate Cancer (Million US$), 2009 - 2018
  • Figure 5-24: United States - Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2019 - 2025
  • Figure 5-25: United States - Proton Therapy Market by Breast Cancer (Million US$), 2009 - 2018
  • Figure 5-26: United States - Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2019 - 2025
  • Figure 5-27: United States - Proton Therapy Market by Other Cancer (Million US$), 2009 - 2018
  • Figure 5-28: United States - Forecast for Proton Therapy Market by Other Cancer (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million US$), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue, (Million US$), 2019 - 2025
  • Figure 11-1: United States - Numbers of Patient Diagnosed With cancer (In Number), 2014 - 2018
  • Figure 11-2: United States - Forecast for Numbers of Patient Diagnosed With cancer (In Number), 2019 - 2025
目次

United States is the hub of proton therapy industry where various advanced and children specialist centers and preferential facilities are available for the child. In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase. Proton therapy centers are growing at a rapid pace in United States as its cancer incidences are raising and there are more patients eligible for treatment than actually resources available for them. Proton therapy is one of the advanced techniques of radiotherapy which produces optimal amount of radiation or pinpoint radiation to kill tumor and mitigate radiation exposure to healthy tissues or cells. The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025. But the actual market is merely 10% of the potential market due to demand-supply mismatch.

Proton therapy is a non-invasive procedure that is used for the treatment of multiple cancers like CNS Cancer, Head & Neck Cancer, Prostate Cancer, Breast Cancer and Lung Cancer etc. People across the world are looking for the non-invasive procedure because of its effectiveness and painless outcome. The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

Besides, proton therapy can be an effective treatment for recurrent tumors. Proton therapy is one of the effective treatments for pediatric patients rather than conventional radiotherapy and surgery that include various risks and complications. Additionally, children body is prone to the re-occurrence of cancer and proton therapy plays an essential role by preventing from re-occurrence. The survival rate of proton therapy is nearly 90 percent which is far better than the traditional technique to treat cancer.

"United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" is a report published by Renub Research. In this report, we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about the list of all operational and Proton Therapy centers going to open in future; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

  • 1. Actual Market is the current market which is already present
  • 2. Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year

Patient Numbers for the Treatment of Proton Therapy in United States

In this report, we have portrayed proton therapy patients into two parts; potential patients and actual one. We have also categorized the proton therapy patient numbers on the basis of cancer type into 14 sections; Central Nervous System Tumors, Intraocular Melanomas, Pituitary Neoplasms, Base of Skull / Axial Skeleton, Head and Neck, Lung Cancers, Retroperitoneal Sarcoma, Pediatric (Up to Age 18), Gastrointestinal Tract, Urinary Tract, Female Pelvic Organs, Prostate Cancer, Breast Cancer and Other.

Proton Therapy Market for 14 Types of Cancer in United States

The proton therapy market is divided into two parts; potential proton therapy market and actual proton therapy market. This report studies the 14 cancer types proton therapy market Retroperitoneal Sarcoma, Central Nervous System Tumors, Pituitary Neoplasms, Intraocular Melanomas, Lung Cancers, Base of Skull / Axial Skeleton, Gastrointestinal Tract, Pediatric (Up to Age 18), Urinary Tract, Head and Neck, Breast Cancer, Female Pelvic Organs, Prostate Cancer, and Other.

According to Renub Research Analysis, the more patients of cancer would get proton therapy treatment in United States due to rising prevalence of cancer and an increasing number of the advanced proton therapy center. Additionally, increasing technological development in Proton therapy and increasing efficiencies will further boost the market of proton therapy in United States.

Number of Patients Treated in each Proton Therapy Center of United States

In this report, we have done a full assessment of proton therapy center of United States with their treatment capabilities and technology used. Currently, there are 31 operational centers for proton therapy in United States, and XX centers are in construction phase and XX are in planning phase. In this report we have provided complete patients number treated with proton therapy by each proton therapy center of United States.

Reimbursement Policy Insights

Here, we have done an in-depth analysis of reimbursement policies in United States. Here, we have fragmented the reimbursement policy into two parts; the first one is by patient's perspective, and the second one is by manufacturer, stakeholder and institutional perspective.

Key Companies Covered

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

United States Proton Therapy Market & Patient Numbers has been analyzed from two viewpoints

  • Actual & Potential Market
  • Actual & Potential Number of Patients Treated

14 Types of Cancer - Patient Numbers & Market

  • 1. Central Nervous System Tumors Cancer
  • 2. Pituitary Neoplasms Cancer
  • 3. Intraocular Melanomas Cancer
  • 4. Lung Cancers
  • 5. Base of Skull / Axial Skeleton Cancer
  • 6. Gastrointestinal Tract Cancer
  • 7. Pediatric (Up to Age 18) Cancer
  • 8. Urinary Tract Cancer
  • 9. Head and Neck Cancer
  • 10. Breast Cancer
  • 11. Female Pelvic Organs Cancer
  • 12. Prostate Cancer
  • 13. Retroperitoneal Sarcoma Cancer
  • 14. Other Cancer

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Potential Proton Therapy Market

5. Number of Patients - United States Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Potential Numbers

6. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2025)

  • 6.1. Central Nervous System Tumors
  • 6.2. Intraocular Melanomas Cancer
  • 6.3. Pituitary Neoplasms Cancer
  • 6.4. Base of Skull / Axial Skeleton Cancer
  • 6.5. Head and Neck Cancer
  • 6.6. Lung Cancer
  • 6.7. Retroperitoneal Sarcoma Cancer
  • 6.8. Pediatric Cancer Cases (Up to Age 18)
  • 6.9. Gastrointestinal Tract Cancer
  • 6.10. Urinary Tract Cancer
  • 6.11. By Female Pelvic Organs Cancer
  • 6.12. Prostate Cancer
  • 6.13. Breast Cancer
  • 6.14. Other Cancer

7. Cancer Types - United States Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System Tumors
  • 7.2. Intraocular Melanomas Cancer
  • 7.3. Pituitary Neoplasms Cancer
  • 7.4. Base of Skull / Axial Skeleton Cancer
  • 7.5. Head and Neck Cancer
  • 7.6. Lung Cancer
  • 7.7. Retroperitoneal Sarcoma Cancer
  • 7.8. Pediatric Cancer (Up to Age 18)
  • 7.9. Gastrointestinal Tract Cancer
  • 7.10. Urinary Tract Cancer
  • 7.11. Female Pelvic Organs Cancer
  • 7.12. Prostate Cancer
  • 7.13. Breast Cancer
  • 7.14. Other Cancer

8. United States - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers
  • 8.3. Planning Proton Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
  • 9.2. UCSF - CNL Proton Therapy Center (2008 - 2015)
  • 9.3. Boston (NPTC) Proton Therapy Center (2008 - 2016)
  • 9.4. Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
  • 9.5. Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
  • 9.6. UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
  • 9.7. Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
  • 9.8. CDH Warrenville Proton Therapy Center (2010 - 2016)
  • 9.9. Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
  • 9.10. Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
  • 9.11. New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
  • 9.12. Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
  • 9.13. St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
  • 9.14. Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
  • 9.15. San Diego (Scripps PTC) (2014 - 2017)
  • 9.16. Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
  • 9.17. Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
  • 9.18. Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
  • 9.19. Brunswick (Laurie PC) Proton Therapy Center (2015)
  • 9.20. Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
  • 9.21. Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
  • 9.22. Phoenix (Mayo PBTC) Proton Therapy Center (2016)
  • 9.23. Baltimore (Maryland PTC) Proton Therapy Center (2016)
  • 9.24. Cincinnati (Children's PTC) Proton Therapy Center (2016)
  • 9.25. Orlando (Orlando Health PTC) Proton Therapy Center (2016)
  • 9.26. Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

10. Proton Therapy - Reimbursement Policies

  • 10.1. Proton Therapy Reimbursement Policies for Patients
  • 10.2. Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

11. Components of a Standard Proton Therapy Center

  • 11.1. Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 10.2.2. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in United States

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operations Challenges
Back to Top